Related Experiment Video
Updated: Aug 7, 2026

Gene Transfer for Ischemic Heart Failure in a Preclinical Model
Published on: May 15, 2011
Acute myocardial infarction. Treatment in the coronary care unit
1Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor 48109-0366.
Insights
Acute myocardial infarction management is evolving. Current strategies focus on reperfusion therapies like thrombolytics and aspirin, with angioplasty and transplantation for complex cases. Future approaches may involve polypharmacy.
Area of Science:
- Cardiology
- Emergency Medicine
Background:
- Acute myocardial infarction (MI) management is rapidly changing.
- The "reperfusion era" emphasizes early intervention.
Purpose of the Study:
- To outline current and emerging strategies for acute myocardial infarction.
- To discuss the role of various treatments in MI management.
Main Methods:
- Review of current therapeutic approaches for acute MI.
- Discussion of interventional and pharmacological treatments.
Main Results:
- Intravenous thrombolytic therapy and aspirin are standard pre-hospital treatments.
- Percutaneous transluminal coronary angioplasty and cardiac transplantation are options for specific patient groups.
- Polypharmacy is emerging as a key strategy.
Conclusions:
- Current MI management involves reperfusion therapies, with interventional options for non-responders.
- The future of acute MI care may involve a "cocktail era" of polypharmacy.
Abstract:
Management of the patient with acute myocardial infarction is in flux. In the current "reperfusion era," many patients receive intravenous thrombolytic therapy and aspirin before admission to the coronary care unit. Appropriate use of drugs limits expansion of the infarct and reduces mortality rates in patients with uncomplicated myocardial infarction. Percutaneous transluminal coronary angioplasty may be necessary in those who are not candidates for drug treatment or who show recurrent ischemia after thrombolysis, while cardiac transplantation may be the only hope for patients with multivessel disease who are in cardiogenic shock. The "cocktail era," in which polypharmacy is both acceptable and effective, will likely be the next stage in management of acute myocardial infarction.
More Related Videos
10:01Improvement of a Closed Chest Porcine Myocardial Infarction Model by Standardization of Tissue and Blood Sampling Procedures
Published on: March 12, 2018
07:40Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
Published on: May 26, 2023
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome IV: Interprofessional Care
Acute Coronary Syndrome V: Nursing Management
Angina V: Nursing Management